PABLO
GUISADO VASCO
PROFESOR
![Foto de PABLO](/img/uploaded/CF50829333FAB8A9FA2B4553FA8F2102.jpg)
![Foto de Hospital Universitario de Salamanca](/img/noimage_org.png)
Hospital Universitario de Salamanca
Salamanca, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Salamanca (5)
2018
-
Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)
Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129
2017
-
Characterization and risk estimate of cancer in patients with primary Sjögren syndrome
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2014
2012
-
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases
British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171
-
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
Leukemia and Lymphoma, Vol. 53, Núm. 5, pp. 812-819